How Does Segmental Outflow Affect Outflow Resistance?
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2009
Grant ID
G2006057
Acknowledgement
Goals
Glaucoma is a disease typically associated with elevated intraocular pressure (IOP) caused by increased resistance to aqueous humor outflow. Glaucoma is treated clinically by reducing IOP, but the precise factors responsible for controlling IOP and outflow resistance are not well understood.
Dr. Overby proposes to study how the hydrodynamic patterns of aqueous humor outflow change in response to stimuli that affect outflow resistance. His hypothesis is because aqueous humor is confined to flow through only a fraction of total area of outflow pathway, outflow resistance is correlated to the area that is actively involved in hydrodynamic filtration of aqueous humor.
Summary
To test this hypothesis, he will aim to develop a new tracer method that will combine with confocal microscopy to visualize the hydrodynamic patterns of outflow and measure the active area of aqueous humor filtration in human eyes. The second aim is to use this tracer technique to quantify the relationship between outflow resistance and filtration area for changing IOP that causes a change in outflow resistance. The long-term goal of this project is to translate this fundamental understanding of outflow hydrodynamics into a strategy to reduce outflow resistance and IOP in glaucomatous eyes.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
W. Daniel Stamer, PhD
Current Organization
Duke University
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
W. Daniel Stamer, PhD
Current Organization
Duke University
National Glaucoma Research
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California